USD10
ORIC Shares
About ORIC PharmaceuticalsORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
USD10
ORIC Shares
About ORIC PharmaceuticalsORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$1.21B
OPEN PRICE
$10.42
LOW (1Y)
$4.52
HIGH (1Y)
$14.93
LOW (24H)
$10.30
HIGH (24H)
$10.98
VOLUME (24H)
$1.75M
28.31%
Price history
Time | Price | Change |
|---|---|---|
Today | $10.42 | |
1 Day | $10.75 | |
1 Week | $9.84 | |
1 Month | $11.12 | |
1 Year | $4.87 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
